عنوان

Management of urothelial carcinoma /

شابک

9789811055010

شابک

9789811055027

شابک

9789811055034

شابک

9811055017

شابک

9811055025

شابک

9811055033

شابک اشتباه

9789811055010

عنوان اصلي

Management of urothelial carcinoma /

نام عام مواد

[Book]

نام نخستين پديدآور

Ja Hyeon Ku, editor.

محل نشرو پخش و غیره

Singapore :

نام ناشر، پخش کننده و غيره

Springer,

تاریخ نشرو بخش و غیره

2019.

نام خاص و کميت اثر

1 online resource (vi, 196 pages) :

ساير جزييات

illustrations (some color)

متن يادداشت

Includes index.

متن يادداشت

Intro; Contents; Part I: Non-muscle Invasive Bladder Cancer; 1: Epidemiology, Etiology, and Histopathology; 1.1 Epidemiology; 1.2 Etiology; 1.2.1 Genetic Factors; 1.2.2 Environmental Factors; References; 2: Histopathology; 2.1 Urothelial Carcinoma; 2.1.1 Carcinoma In Situ; 2.1.2 Lymphovascular Invasion; 2.1.3 Histologic Variant of Urothelial Carcinoma; 2.1.4 T1 Sub-staging; References; 3: Symptoms and Work-Up; 3.1 Hematuria; 3.1.1 Diagnostic Value of Hematuria; 3.1.2 Gender Difference and Hematuria (SEER DB); 3.1.3 Asymptomatic Microscopic Hematuria

متن يادداشت

3.2 Lower Urinary Tract Symptoms3.3 Modalities for Upper Tract Evaluation; References; 4: Cystoscopy; 4.1 Indication; 4.2 Instrument; 4.3 Procedure; 4.3.1 Preparation; 4.3.2 Anesthesia; 4.3.3 Recommendation for Prophylactic Antibiotics; 4.3.4 Bladder Inspection; 4.4 Typical Findings of Bladder Cancer; 4.5 Benefits for Using Flexible Cystoscopy in Male Patient; 4.6 Advance Cystoscopy Technique (NBI/PDD/OCT); 4.6.1 Narrowband Imaging (NBI); 4.6.2 Photodynamic Diagnosis; 4.6.3 Microscopic Imaging; 4.6.4 Other Upcoming Imaging Technologies; 4.7 Follow-Up; References

متن يادداشت

5.2.2.4 Urine MicroRNA5.2.3 Cell-Based Biomarker; 5.2.3.1 ImmunoCyt/uCyt; 5.2.3.2 Fluorescence In Situ (FISH) Test; References; 6: Modifiable Risk Factor to Prevention; 6.1 Smoking Cessation; 6.2 Avoid Occupational Carcinogen Exposure; 6.3 Other Modifiable Factors; References; 7: Transurethral Resection of Bladder Tumor; 7.1 Instrument; 7.2 Procedure; 7.2.1 Preparation; 7.2.2 Tumor Resection; 7.3 Complication; 7.4 Monopolar/Bipolar TURBT; 7.5 Repeated TURBT; 7.6 Transurethral Prostate Biopsy; 7.7 Bladder Random Biopsy (Mapping Biopsy); 7.8 Routine Biopsy after BCG

متن يادداشت

5: Urine Cytology and Emerging Biomarkers5.1 Urine Cytology; 5.1.1 Normal Findings in Cytology; 5.1.2 Malignant Findings in Cytology; 5.1.3 Routine Evaluation of Urine Cytology in Hematuria Patients; 5.1.4 Washing Cytology vs. Voided Urine Cytology; 5.1.5 The Paris System for Reporting Urinary Cytology (PSRUC); 5.1.5.1 Pros and Cons of the Paris System for Reporting Urinary Cytology; 5.2 Biomarker; 5.2.1 Currently Available Biomarkers; 5.2.2 Urinary Biomarker; 5.2.2.1 Nuclear Matrix Protein-22 (NMP22); 5.2.2.2 Bladder Tumor Antigen (BTA); 5.2.2.3 Urine Protein

متن يادداشت

7.9 En Bloc Resection of Bladder TumorReferences; 8: Intravesical Instillation Therapy; 8.1 Immediate Post-TURBT Intravesical Chemotherapy; 8.1.1 Efficacy; 8.1.2 Protocol; 8.2 Induction and Maintenance Intravesical Chemotherapy; 8.2.1 Chemotherapeutic Agents; 8.2.2 Protocol; 8.2.3 Optimization; 8.3 Intravesical BCG Immunotherapy; 8.3.1 Introduction; 8.3.2 BCG Strain; 8.3.3 Protocol; 8.3.4 Adverse Effects; 8.3.5 BCG-Unresponsive NMIBC; 8.3.6 BCG Shortages; 8.4 New Definition of Disease Progression; References; 9: Early Radical Cystectomy

بدون عنوان

0

بدون عنوان

8

بدون عنوان

8

بدون عنوان

8

بدون عنوان

8

متن يادداشت

This book provides a comprehensive overview of contemporary evidence-based management of urothelial carcinoma. The first part of the book is devoted to urothelial carcinoma of the bladder and includes detailed description of the diagnosis and treatment of non-muscle-invasive, muscle-invasive, and advanced or metastatic disease. Attention then turns to upper tract urothelial carcinoma (UTUC), with individual chapters on diagnosis, nephron-sparing surgery, nephroureterectomy, and treatment of advanced or metastatic UTUC. The text is supported by many illustrations, photos, and tables that clarify management, and surgical video clips are also available to readers. The book will be a welcome addition to the literature as progress continues to be made in understanding the exact pathophysiology of urothelial carcinoma and in developing more effective diagnostic and therapeutic modalities. It will be useful both to researchers in the field of urothelial carcinoma and to clinicians, including especially residents and fellows.

منبع سفارش / آدرس اشتراک

Springer Nature

شماره انبار

com.springer.onix.9789811055027

عنوان

Management of Urothelial Carcinoma.

شماره استاندارد بين المللي کتاب و موسيقي

9789811055010

موضوع مستند نشده

Bladder-- Cancer-- Treatment.

موضوع مستند نشده

Bladder-- Cancer-- Treatment.

موضوع مستند نشده

MED088000

موضوع مستند نشده

MJS

موضوع مستند نشده

MJS

شماره

ويراست

شماره رده

مستند نام اشخاص تاييد نشده

Ku, Ja Hyeon

تاريخ عمليات

20200823221552.0

قواعد فهرست نويسي ( بخش توصيفي )

pn

نام الکترونيکي

نوع ماده

[Book]

تكميل شده

Y